Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association.
暂无分享,去创建一个
S. Grundy | R. Eckel | B. Howard | S. Smith | G. Burke | I. Benjamin | A. Chait | W. Mitch | J. Sowers
[1] [Kidney diseases in diabetes in children]. , 1963, La Semana medica.
[2] C. Meinert,et al. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results. , 1970, Diabetes.
[3] A. Grishman,et al. New type of cardiomyopathy associated with diabetic glomerulosclerosis. , 1972, The American journal of cardiology.
[4] S. Ahmed,et al. Evidence for cardiomyopathy in familial diabetes mellitus. , 1977, The Journal of clinical investigation.
[5] S. Rostand,et al. Racial differences in the incidence of treatment for end-stage renal disease. , 1982, The New England journal of medicine.
[6] C. Mogensen,et al. The Stages in Diabetic Renal Disease: With Emphasis on the Stage of Incipient Diabetic Nephropathy , 1983, Diabetes.
[7] T. Regan. Congestive heart failure in the diabetic. , 1983, Annual review of medicine.
[8] K. Minaker,et al. Characterization of the insulin resistance of aging. , 1983, The Journal of clinical investigation.
[9] S. Colagiuri,et al. The Diabetes Control and Complications Trial , 1983, Henry Ford Hospital medical journal.
[10] S. Lillioja,et al. Relationship between obesity and maximal insulin-stimulated glucose uptake in vivo and in vitro in Pima Indians. , 1984, The Journal of clinical investigation.
[11] F. Marcus,et al. Prognosis of patients with diabetes mellitus after acute myocardial infarction. , 1984, The American journal of cardiology.
[12] C. Mogensen,et al. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. , 1984, The New England journal of medicine.
[13] R. Williams,et al. Williams Textbook of endocrinology , 1985 .
[14] R. Nesto,et al. Asymptomatic myocardial ischemia in diabetic patients. , 1986, The American journal of medicine.
[15] W. Knowler,et al. Effect of Proteinuria on Mortality in NIDDM , 1988, Diabetes.
[16] T. Farag. Familial hypercholesterolemia. , 1988, Journal of the Royal Society of Medicine.
[17] A. Cerami,et al. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. , 1988, The New England journal of medicine.
[18] H. Parving,et al. Prevalence of microalbuminuria, arterial hypertension, retinopathy, and neuropathy in patients with insulin dependent diabetes , 1988, British medical journal.
[19] W C Willett,et al. Low-density lipoprotein subclass patterns and risk of myocardial infarction. , 1988, JAMA.
[20] T. Regan,et al. Cardiac disease in diabetes. , 1989, Postgraduate medicine.
[21] D. Singer,et al. Diabetic Myocardial Infarction: Interaction of Diabetes With Other Preinfarction Risk Factors , 1989, Diabetes.
[22] P. Savage,et al. Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. , 1989, The New England journal of medicine.
[23] P. Savage,et al. Role of Cardiovascular Risk Factors in Prevention and Treatment of Macrovascular Disease in Diabetes , 1989, Diabetes Care.
[24] A. Jaffe,et al. The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. The MILIS Study Group. , 1989, Journal of the American College of Cardiology.
[25] S. Factor,et al. A comparison of the pathological spectrum of hypertensive, diabetic, and hypertensive-diabetic heart disease. , 1990, Circulation.
[26] J. Gillaspy,et al. Racial differences in the incidence of end-stage renal disease in types I and II diabetes mellitus. , 1990, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[27] A. Krolewski,et al. Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. , 1990, Annals of internal medicine.
[28] R. Campbell,et al. Coronary heart disease in high-risk populations: lessons from Finland. , 1990, European heart journal.
[29] M. King,et al. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. , 1990, Circulation.
[30] J. Sowers. Insulin resistance and hypertension , 1990, Molecular and Cellular Endocrinology.
[31] S. Haffner,et al. Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? , 1990, JAMA.
[32] J. Briggs,et al. Outcome of renal replacement treatment in patients with diabetes mellitus. , 1990, BMJ.
[33] Standards of Medical Care for Patients With Diabetes Mellitus , 1991, Diabetes Care.
[34] K. Derfler,et al. Renal replacement therapy in type 2 diabetic patients: 10 years' experience. , 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[35] A. Zwinderman,et al. Increased morbidity and mortality in patients with diabetes mellitus after kidney transplantation as compared with non-diabetic patients. , 1992, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[36] Richard A. Kronmal,et al. Distribution and Correlates of Sonographically Detected Carotid Artery Disease in the Cardiovascular Health Study , 1992, Stroke.
[37] R J Jarrett,et al. Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: a twenty-three year follow-up study. , 1992, Kidney international.
[38] A. Fitzgerald,et al. Prospective Study of Microalbuminuria as Predictor of Mortality in NIDDM , 1992, Diabetes.
[39] R. Nesto,et al. Acute myocardial infarction in the diabetic patient: pathophysiology, clinical course and prognosis. , 1992, Journal of the American College of Cardiology.
[40] J. Sowers,et al. Insulin Resistance in Hypertension: A Focused Review , 1993, The American journal of the medical sciences.
[41] E. Barrett-Connor,et al. Prevalence of Cardiovascular and Renal Complications in Older Adults With Normal or Impaired Glucose Tolerance or NIDDM: A population-based study , 1993, Diabetes Care.
[42] B. Kasiske,et al. Effect of Antihypertensive Therapy on the Kidney in Patients with Diabetes: A Meta-Regression Analysis , 1993, Annals of Internal Medicine.
[43] S. Genuth,et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.
[44] L. Agodoa,et al. The excess risk of treated end-stage renal disease in blacks in the United States. , 1993, Journal of the American Society of Nephrology : JASN.
[45] R. Bain,et al. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. , 1993, The New England journal of medicine.
[46] M. Lishner,et al. Long-Term Stabilizing Effect of Angiotensin-Converting Enzyme Inhibition on Plasma Creatinine and on Proteinuria in Normotensive Type II Diabetic Patients , 1993, Annals of Internal Medicine.
[47] J. Neaton,et al. Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial , 1993, Diabetes Care.
[48] Richard Barnett,et al. Diabetes mellitus. , 1993, The Medical journal of Australia.
[49] V. Brezinka,et al. Coronary heart disease risk factors in women. , 1994, European heart journal.
[50] D. Bell,et al. Stroke in the diabetic patient. , 1994, Diabetes care.
[51] A Fournier,et al. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. , 1994, The New England journal of medicine.
[52] Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) , 1994, The Lancet.
[53] L. Wilkins. National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). , 1994 .
[54] J. Stengård,et al. Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease , 1994, The Lancet.
[55] A. Folsom,et al. Relation of Carotid Artery Wall Thickness to Diabetes Mellitus, Fasting Glucose and Insulin, Body Size, and Physical Activity , 1994, Stroke.
[56] G. Reaven. Insulin Resistance and Coronary Heart Disease , 1995 .
[57] V. Fuster,et al. Preventing heart attack and death in patients with coronary disease. , 1995, Circulation.
[58] G. Dailey,et al. Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM. Evidence from studies in normal glucose-tolerant individuals with a first-degree NIDDM relative. , 1995, JAMA.
[59] S. Grundy,et al. Relationships of generalized and regional adiposity to insulin sensitivity in men. , 1995, The Journal of clinical investigation.
[60] S. Hunt,et al. Hypertension, dyslipidemia, and insulin resistance: links in a chain or spokes on a wheel? , 1996, Current opinion in lipidology.
[61] J. Herlitz,et al. Mortality and Morbidity in Diabetic and Nondiabetic Patients During a 2-Year Period After Coronary Artery Bypass Grafting , 1996, Diabetes Care.
[62] D L Rothman,et al. Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects. , 1996, The New England journal of medicine.
[63] G. Reaven,et al. Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system. , 1996, The New England journal of medicine.
[64] J. Willerson. Effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. , 1996, Circulation.
[65] M. Austin,et al. Small, dense low density lipoproteins, the insulin resistance syndrome and noninsulin-dependent diabetes , 1996, Current opinion in lipidology.
[66] J. Tobin,et al. The effect of age on insulin resistance and secretion: a review. , 1996, Seminars in nephrology.
[67] D. Faxon,et al. Coronary angioplasty in diabetic patients. The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. , 1996, Circulation.
[68] J. Pugh,et al. Non-Insulin-Dependent Diabetes Mellitus in Minorities in the United States , 1996, Annals of Internal Medicine.
[69] L. Kuller,et al. Coronary artery disease in IDDM. Gender differences in risk factors but not risk. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[70] P. Bennett,et al. Kidney Diseases in Diabetes , 1996 .
[71] K. Sørensen,et al. Incipient Cardiomyopathy in Young Insulin‐dependent Diabetic Patients: A Seven‐year Prospective Doppler Echocardiographic Study , 1996, Diabetic medicine : a journal of the British Diabetic Association.
[72] S M Grundy,et al. Small LDL, atherogenic dyslipidemia, and the metabolic syndrome. , 1997, Circulation.
[73] G. Dagenais,et al. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study. , 1997, Circulation.
[74] Terje R Pedersen,et al. Cholesterol Lowering With Simvastatin Improves Prognosis of Diabetic Patients With Coronary Heart Disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) , 1997, Diabetes Care.
[75] M. Fantone,et al. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus , 1997, Diabetes Care.
[76] Detection. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI) , 1997 .
[77] Impaired Glucose Tolerance, Insulin Resistance and Cardiovascular Disease , 1997, Diabetic medicine : a journal of the British Diabetic Association.
[78] E. Antman,et al. ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). , 2002, Circulation.
[79] E. Kraegen,et al. PATHOGENESIS OF THE INSULIN RESISTANCE SYNDROME (SYNDROME X) , 1997, Clinical and experimental pharmacology & physiology.
[80] M. Hammami. Diabetes Mellitus: A Fundamental and Clinical Text , 1997 .
[81] T. B. Investigators,et al. Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI) , 1997, Circulation.
[82] J. Spertus,et al. Bypass surgery versus coronary angioplasty for revascularization of treated diabetic patients. , 1997, Circulation.
[83] R. Weinshilboum,et al. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. , 1997, Archives of internal medicine.
[84] I. Ockene,et al. Cigarette smoking, cardiovascular disease, and stroke: a statement for healthcare professionals from the American Heart Association. American Heart Association Task Force on Risk Reduction. , 1997, Circulation.
[85] D. Cook,et al. Prevalence, detection, and management of cardiovascular risk factors in different ethnic groups in south London , 1997, Heart.
[86] M. Walker,et al. Multiple metabolic abnormalities in normal glucose tolerant relatives of NIDDM families , 1997, Diabetologia.
[87] H. Mcgill,et al. Determinants of atherosclerosis in the young , 1998 .
[88] D. Levy,et al. Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.
[89] C. Spurr,et al. Two Cases of Severe Clinical and Histologic Hepatotoxicity Associated with Troglitazone , 1998, Annals of Internal Medicine.
[90] R. Holman,et al. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) , 1998, The Lancet.
[91] R. Collins,et al. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. , 1998, The New England journal of medicine.
[92] B. Neuschwander‐Tetri,et al. Troglitazone-Induced Hepatic Failure Leading to Liver Transplantation: A Case Report , 1998, Annals of Internal Medicine.
[93] P. McKeigue,et al. Plasminogen activator inhibitor-1 activity is independently related to both insulin sensitivity and serum triglycerides in 70-year-old men. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[94] Terminal Dehydration as an Alternative to Physician-Assisted Suicide , 1998 .
[95] S M Grundy,et al. Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association. , 1998, Circulation.
[96] M. Trovati,et al. Insulin, insulin resistance and platelet function: similarities with insulin effects on cultured vascular smooth muscle cells , 1998, Diabetologia.
[97] B. Davis,et al. Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investigators. , 1998, Circulation.
[98] R. Holman,et al. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .
[99] G. Riccardi,et al. Plasma Fibrinogen: A New Factor of the Metabolic Syndrome: A population-based study , 1998, Diabetes Care.
[100] Prevalence of diagnosed diabetes among American Indians/Alaskan Natives--United States, 1996. , 1998, MMWR. Morbidity and mortality weekly report.
[101] Uk-Prospective-Diabetes-Study-Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) , 1998, The Lancet.
[102] J. Gerich,et al. The genetic basis of type 2 diabetes mellitus: impaired insulin secretion versus impaired insulin sensitivity. , 1998, Endocrine reviews.
[103] M. Laakso,et al. Epidemiology of risk factors for cardiovascular disease in diabetes and impaired glucose tolerance. , 1997, Atherosclerosis.
[104] H. Mcgill,et al. Determinants of atherosclerosis in the young. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. , 1998, The American journal of cardiology.
[105] S. Kahn,et al. Human aging is associated with parallel reductions in insulin and amylin release. , 1998, The American journal of physiology.
[106] S. Dinneen,et al. HIV Testing in Pregnant Women , 1998, Annals of Internal Medicine.
[107] S. Grundy. Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome. , 1998, The American journal of cardiology.
[108] Grundy,et al. Abnormal metabolism of free fatty acids in hypertriglyceridaemic men: apparent insulin resistance of adipose tissue , 1998, Journal of internal medicine.
[109] S. Haffner. Management of Dyslipidemia in Adults With Diabetes , 1998, Diabetes Care.
[110] P. Savage,et al. Risk factor clustering in the insulin resistance syndrome. The Strong Heart Study. , 1998, American journal of epidemiology.
[111] R. Baumgartner,et al. Prevalences of Type 2 Diabetes, the Insulin Resistance Syndrome, and Coronary Heart Disease in an Elderly, Biethnic Population , 1998, Diabetes Care.
[112] American Diabetes Association: clinical practice recommendations 1999. , 1999, Diabetes care.
[113] E. Vittinghoff,et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. , 1998, JAMA.
[114] P. Wilson,et al. Diabetes mellitus and coronary heart disease. , 2001, Endocrinology and metabolism clinics of North America.